Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease
Authors:
- Vincenzo ProviteraVPVincenzo Provitera
- Valeria IodiceVIValeria Iodice
- Fiore ManganelliFMFiore Manganelli
- Stefania MozzilloSMStefania Mozzillo
- Giuseppe CaporasoGCGiuseppe Caporaso
- Annamaria StancanelliASAnnamaria Stancanelli
- Ilaria BorrecaIBIlaria Borreca
- Marcello EspositoMEMarcello Esposito
- Raffaele DubbiosoRDRaffaele Dubbioso
- Rosa IodiceRIRosa Iodice
- Floriana VitaleFVFloriana Vitale
- Shiwen KoaySKShiwen Koay
- 22 March 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 98 (12) , e1282-e1291
Abstract
Background and Objectives Sudomotor impairment has been recognized as a key feature in differentiating Parkinson disease (PD) and multiple system atrophy–parkinsonian type (MSA-P), with the latter characterized by diffuse anhidrosis in prospective study, including patients in late stage of disease. We aimed to evaluate morphologic and functional postganglionic sudomotor involvement in patients with newly diagnosed MSA-P and PD to identify possible biomarkers that might be of help in differentiating the 2 conditions in the early stage. Methods One hundred patients with parkinsonism within 2 years from onset of motor symptoms were included in the study. At the time of recruitment, questionnaires to assess nonmotor, autonomic, and small fiber symptoms were administered, and patients underwent postganglionic sudomotor function assessment by the dynamic sweat test and punch skin biopsy from the distal leg. Skin samples were processed for indirect immunofluorescence with a panel of antibodies, including noradrenergic and cholinergic markers. The density of intraepidermal, sudomotor, and pilomotor nerve fibers was measured on confocal images with dedicated software. A follow-up visit 12 months after recruitment was performed to confirm the diagnosis. Results We recruited 57 patients with PD (M/F 36/21, age 63.5 ± 9.4 years) and 43 patients with MSA-P (M/F 27/16, age 62.3 ± 9.0 years). Clinical scales and questionnaires showed a more severe clinical picture in patients with MSA-P compared to those with PD. Sweating output and intraepidermal, pilomotor, and sudomotor nerve densities, compared to controls, were lower in both groups but with a greater impairment in patients with MSA-P. Pilomotor and sudomotor nerve density correlated with sweating function and with nonmotor clinical symptoms. A composite sudomotor parameter defined as the arithmetic product of sweat production multiplied by the density of sudomotor fibers efficiently separated the 2 populations; the receiver operating characteristics curve showed an area under the curve of 0.83. Discussion Dynamic sweat test and the quantification of cutaneous autonomic nerves proved to be a sensitive morpho-functional approach to assess the postganglionic component of the sudomotor pathway, revealing a more severe involvement in MSA-P than in PD early in the disease course. This approach can be applied to differentiate the 2 conditions early. Classification of Evidence This study provides Class II evidence that postganglionic sudomotor morpho-functional assessment accurately distinguish patients with PD from patients with MSA-P.Keywords
This publication has 39 references indexed in Scilit:
- α‐Synuclein: The Long Distance RunnerBrain Pathology, 2013
- COMPASS 31: A Refined and Abbreviated Composite Autonomic Symptom ScoreMayo Clinic Proceedings, 2012
- Quantification of pilomotor nervesNeurology, 2010
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve SocietyEuropean Journal of Neurology, 2010
- Evaluation of sudomotor function in diabetes using the dynamic sweat testNeurology, 2010
- Intraepidermal nerve fiber density and its application in sarcoidosisNeurology, 2009
- Prospective Differentiation of Multiple System Atrophy From Parkinson Disease, With and Without Autonomic FailureArchives of Neurology, 2009
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- Prevalence and incidence of Parkinson's disease in EuropeEuropean Neuropsychopharmacology, 2005
- ParkinsonismNeurology, 1967